New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 5, 2012
10:01 EDTMUSA, CHTR, ADT, BSMX, KYTH, ANFI, WDAY, RGLS, ICPT, AMBA, SSTKOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ADT Corp. (ADT) initiated with a Buy at Citigroup... Ambarella (AMBA) initiated with a Buy at Deutsche Bank... Amira Nature Foods (ANFI) initiated with a Buy at Deutsche Bank... Charter (CHTR) initiated with an Underweight at Barclays... Intercept Pharmaceuticals (ICPT) initiated with a Buy at Needham... Kythera Biopharmaceuticals (KYTH) initiated with a Neutral at Goldman... Metals USA (MUSA) initiated with an Outperform at Wells Fargo... Regulus Therapeutics (RGLS) initiated with a Buy at Needham... Santander Mexico (BSMX) initiated with a Buy at Citigroup... Shutterstock (SSTK) initiated with a Buy at Jefferies... Workday (WDAY) initiated with a Buy at Canaccord.
News For ADT;AMBA;ANFI;CHTR;ICPT;KYTH;MUSA;RGLS;BSMX;SSTK;WDAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
June 19, 2015
10:08 EDTKYTHReceptos jumps amid continued takeover speculation
Speculation of a takeover is again taking shares of Receptos (RCPT) higher. The biopharma company, which has been frequently mentioned as a buyout candidate in blogs and analyst notes, is rumored to have canceled all of its conference appearances. The conference cancelations are unconfirmed, however, and itís not even clear if the company had any scheduled appearances. Further, while KYTHERA (KYTH) was recently acquired after canceling an appearance at a conference, such moves by companies often do not mean acquisition talks are underway. Shares of Receptos are well of their highs but remain up $1.94 to $189.06 in early trading.
09:15 EDTKYTHKYTHERA announces U.S. availability of Kybella
Subscribe for More Information
June 18, 2015
16:32 EDTCHTRCharter issues statement applauding FCC's adoption of Lifeline program
Subscribe for More Information
10:03 EDTAMBAAmbarella volatility at low end of range as shares rally
Subscribe for More Information
June 17, 2015
17:19 EDTKYTHOn The Fly: Top stock stories for Wednesday
Subscribe for More Information
12:23 EDTKYTHOn The Fly: Top stock stories at midday
Subscribe for More Information
10:19 EDTKYTHHigh option volume stocks
Subscribe for More Information
09:35 EDTCHTRGuggenheim to hold a conference
Subscribe for More Information
09:17 EDTKYTHOn The Fly: Pre-market Movers
Subscribe for More Information
09:16 EDTKYTHAllergan buyout of KYTHERA boosts aesthetics portfolio, says BMO Capital
BMO Capital says Allergan's (AGN) buyout of KYTHERA (KYTH) builds out the company's aesthetics portfolio. KYTHERA's double chin treatment Kybella "could be a game changer in contouring," and there is no company better suited to make that happen than Allergan, BMO tells investors in a research note. The firm keeps an Outperform rating on Allergan with a $378 price target.
08:36 EDTSSTKShutterstock shares oversold after Adobe offering unveiled, says RBC Capital
After Adobe (ADBE) announced its stock images offering, Adobe Stock, RBC Capital thinks that the pricing of the offering is less worse than feared for Shutterstock (SSTK). The firm reiterates an $86 price target and Outperform rating on Shutterstock.
07:44 EDTKYTHKYTHERA volatility low into Allergan acquiring for approximately $2.1B
Subscribe for More Information
07:15 EDTKYTHAllergan to host conference call
Conference call to discuss a definitive agreement to acquire KYTHERA Biopharmaceuticals-(KYTH) will be held at 8:30 am on June 17. Webcast Link
07:11 EDTSSTKWorries about Shutterstock competition overdone, says Cantor
Subscribe for More Information
07:04 EDTKYTHAllergan to acquire KYTHERA for $75 per share, or $2.1B
Subscribe for More Information
07:03 EDTKYTHAllergan agrees to acquire KYTHERA for $75 per share or approximately $2.1B
Subscribe for More Information
07:03 EDTKYTHAllergan agrees to acquire KYTHERA for $75 per share or approximately $2.1B
Subscribe for More Information
07:02 EDTKYTHAllergan to acquire KYTHERA for $75 per share, or $2.1B
June 16, 2015
11:46 EDTSSTKShutterstock slides after Adobe launches competing product
Subscribe for More Information
08:47 EDTCHTRNetflix price target raised to $780 from $600 at Needham
Needham analyst Laura Martin raised her price target for shares of Netflix (NFLX) to $780 saying Charter (CHTR) and others offering the streaming service should drive U.S. subscription growth. Further, the company's international subscribers have up to three times faster profit trajectories than their U.S. counterparts, Martin tells investors today in a research note. Netflix will also add advertising revenue "someday," the analyst believes. She keeps a Buy rating on the stock. Netflix shares have sold off recently on Alibaba's (BABA) newly announced streaming service, Martin notes. But she points out China was not in her estimates for Netflix and that she doesn't expect a negative impact on other regions. Shares of Netflix closed yesterday at $654.02.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use